Last updated on March 2020

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

Brief description of study

The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in participants with moderately to severely active CD.

Clinical Study Identifier: NCT03104413

Find a site near you

Start Over

Emeritus Research /ID# 213510

Camberwell, Australia
  Connect »

Footscray Hospital /ID# 211362

Footscray, Australia
  Connect »